CMS Proposes Medicare Payment Reforms for Imaging Services

CMS's new Medicare proposal aims for site-neutral payments for imaging services, potentially saving billions while facing hospital financial challenges.

Impact of Medicaid Cuts on Financially Vulnerable Hospitals

Explore how recent federal cuts threaten over 600 vulnerable hospitals in the U.S., risking essential healthcare services and pushing for legislative reforms.

Medicare Advantage Prior Authorization: Challenges and Compliance Insights

Discover the challenges of Medicare Advantage prior authorization, highlighting denial rates and compliance issues vital for insurers to address in their practices.

CMS Proposes New Regulatory Measures to Combat Medicare Fraud

CMS unveils new measures to combat Medicare fraud, enhancing provider oversight and potentially saving taxpayers $82 million. Discover the impacts now!

First-Quarter Performance of Health Insurance Providers: Insights and Trends

Explore the latest first-quarter financial results of health insurance providers, highlighting key trends, demographic influences, and the role of AI.

New Medicare Initiative for Anti-Obesity Medications—A Step Forward

Discover how a new Medicare initiative expands access to anti-obesity medications, impacting senior healthcare costs and chronic disease management.

Navigating the Changing Landscape of Pharmaceutical Regulation for Insurance

Stay updated on Medicare's proposed changes that could affect drug pricing and health insurance plans, and discover implications of AI in biotechnology.

Elevance Health Challenges Medicare Star Ratings in Legal Dispute

Elevance Health's legal battle against CMS over Medicare Star Ratings could impact $115 million in Quality Bonus Payments. Learn more about industry implications.

Innovative Solutions in Health Management and Insurance

Explore innovative health management solutions, from chronic disease care models to addressing physician burnout. Learn about key developments in healthcare delivery.

Shilpa Medicare and Orion Corporation Collaborate on Nivolumab Biosimilar

Explore the strategic collaboration between Shilpa Medicare and Orion Corporation to launch a nivolumab biosimilar, enhancing access to cancer treatments in Europe.